Mizuo Ando

2.7k total citations
126 papers, 1.2k citations indexed

About

Mizuo Ando is a scholar working on Otorhinolaryngology, Surgery and Oncology. According to data from OpenAlex, Mizuo Ando has authored 126 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Otorhinolaryngology, 53 papers in Surgery and 40 papers in Oncology. Recurrent topics in Mizuo Ando's work include Head and Neck Cancer Studies (47 papers), Head and Neck Surgical Oncology (28 papers) and Ear and Head Tumors (18 papers). Mizuo Ando is often cited by papers focused on Head and Neck Cancer Studies (47 papers), Head and Neck Surgical Oncology (28 papers) and Ear and Head Tumors (18 papers). Mizuo Ando collaborates with scholars based in Japan, United States and China. Mizuo Ando's co-authors include Yuki Saito, Tatsuya Yamasoba, Takahiro Asakage, Go Omura, Kenya Kobayashi, Masafumi Yoshida, Joseph A. Califano, Theresa Guo, Takahito Fukusumi and Chao Liu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Mizuo Ando

93 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mizuo Ando Japan 20 535 400 347 342 213 126 1.2k
Narikazu Uzawa Japan 21 589 1.1× 372 0.9× 333 1.0× 300 0.9× 303 1.4× 147 1.4k
Tomonao Aikawa Japan 18 758 1.4× 287 0.7× 320 0.9× 210 0.6× 138 0.6× 102 1.5k
Takahito Fukusumi Japan 18 531 1.0× 390 1.0× 156 0.4× 221 0.6× 325 1.5× 47 1.1k
Koroku Kato Japan 22 466 0.9× 433 1.1× 141 0.4× 106 0.3× 250 1.2× 51 1.1k
Hajime Sunakawa Japan 15 325 0.6× 388 1.0× 225 0.6× 333 1.0× 103 0.5× 66 966
Christina Springstead Scanlon United States 12 511 1.0× 294 0.7× 96 0.3× 80 0.2× 211 1.0× 16 920
Cláudia Malheiros Coutinho‐Camillo Brazil 23 565 1.1× 460 1.1× 342 1.0× 143 0.4× 299 1.4× 86 1.3k
Junting Huang China 20 318 0.6× 371 0.9× 139 0.4× 43 0.1× 250 1.2× 93 1.0k
Ching‐Cherng Tzeng Taiwan 23 395 0.7× 181 0.5× 198 0.6× 38 0.1× 105 0.5× 54 1.0k
Ryutaro Uchi Japan 24 1.7k 3.1× 471 1.2× 233 0.7× 73 0.2× 1.4k 6.7× 62 2.3k

Countries citing papers authored by Mizuo Ando

Since Specialization
Citations

This map shows the geographic impact of Mizuo Ando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mizuo Ando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mizuo Ando more than expected).

Fields of papers citing papers by Mizuo Ando

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mizuo Ando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mizuo Ando. The network helps show where Mizuo Ando may publish in the future.

Co-authorship network of co-authors of Mizuo Ando

This figure shows the co-authorship network connecting the top 25 collaborators of Mizuo Ando. A scholar is included among the top collaborators of Mizuo Ando based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mizuo Ando. Mizuo Ando is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nagasaki, Joji, Takamasa Ishino, Youki Ueda, et al.. (2025). Close Spatial Interactions between Cancer Cells and Cancer-Associated Fibroblasts Suppress Antitumor Immunity. Cancer Immunology Research. 13(9). 1471–1484.
2.
Makihara, Seiichiro, et al.. (2025). A randomized, double-blind, within-person trial of hot saline at 42 °C for endoscopic sinus surgery. Acta Oto-Laryngologica. 145(12). 1167–1174.
3.
Mitsuhashi, Toshiharu, Naomi Matsumoto, Soshi Takao, et al.. (2025). Association between swimming lessons and rhinitis in school children: A nationwide birth cohort study. International Journal of Pediatric Otorhinolaryngology. 195. 112415–112415.
5.
Ando, Mizuo, Kunihiro Fukushima, & Kazunori Nishizaki. (2024). The discovery of acatalasemia (lack of catalase in the blood) and its significance in human genetics. Proceedings of the Japan Academy Series B. 100(7). 353–367. 2 indexed citations
6.
Ando, Mizuo, et al.. (2024). A case of an electric toothbrush tip penetrating from the oral cavity to the submandibular gland. SHILAP Revista de lepidopterología. 12(6). e8987–e8987.
8.
Tachibana, Tomoyasu, et al.. (2023). A Case of Relapsing Polychondritis Localized to the Nasal Septum Which Showed Spontaneous Healing. Practica Oto-Rhino-Laryngologica. 116(6). 573–577.
9.
Saito, Yuki, Kenya Kobayashi, Osamu Fukuoka, et al.. (2023). Ultra‐high combined positive score and high serum albumin are favorable prognostic biomarkers for immune checkpoint inhibitors in head and neck squamous cell carcinoma. Head & Neck. 46(2). 367–377. 2 indexed citations
10.
Monden, Nobuya, et al.. (2021). Fertility Preservation Therapy Provided for Childhood, Adolescent, and Young Adult Cancer Patients. Practica Oto-Rhino-Laryngologica. 114(12). 957–962.
11.
Liu, Chao, Koji Ebisumoto, Akihiro Sakai, et al.. (2020). Cannabinoids Promote Progression of HPV-Positive Head and Neck Squamous Cell Carcinoma via p38 MAPK Activation. Clinical Cancer Research. 26(11). 2693–2703. 47 indexed citations
12.
Kobayashi, Kenya, Seiichi Yoshimoto, Mizuo Ando, et al.. (2020). Full-coverage TP53 deep sequencing of recurrent head and neck squamous cell carcinoma facilitates prognostic assessment after recurrence. Oral Oncology. 113. 105091–105091. 7 indexed citations
13.
Wang, Zhiyong, Xiaodong Feng, Alfredo Molinolo, et al.. (2019). 4E-BP1 Is a Tumor Suppressor Protein Reactivated by mTOR Inhibition in Head and Neck Cancer. Cancer Research. 79(7). 1438–1450. 54 indexed citations
14.
Liu, Chao, Theresa Guo, Guorong Xu, et al.. (2018). Characterization of Alternative Splicing Events in HPV-Negative Head and Neck Squamous Cell Carcinoma Identifies an Oncogenic DOCK5 Variant. Clinical Cancer Research. 24(20). 5123–5132. 33 indexed citations
15.
Fukusumi, Takahito, Theresa Guo, Akihiro Sakai, et al.. (2017). The NOTCH4HEY1 Pathway Induces Epithelial–Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research. 24(3). 619–633. 71 indexed citations
16.
Shinomiya, Hirotaka, Yuki Saito, Masafumi Yoshida, et al.. (2017). Prognostic value of ALDH2 polymorphism for patients with oropharyngeal cancer in a Japanese population. PLoS ONE. 12(12). e0187992–e0187992. 11 indexed citations
17.
Ebihara, Yasuhiro, Go Omura, Yuki Saito, et al.. (2015). Frequent Copy Gain of the <i>MET</i> Gene in Hypopharyngeal and Laryngeal Cancer in the Japanese Population. Journal of Cancer Therapy. 6(12). 1093–1102.
18.
Omura, Go, et al.. (2013). Salvage surgery for recurrence of hypopharyngeal carcinoma after definitive radiotherapy or chemoradiotherapy. Toukeibu Gan. 39(1). 55–59. 1 indexed citations
19.
Ando, Mizuo, et al.. (2010). A clinical study of glottic carcinoma. Toukeibu Gan. 36(3). 322–326. 1 indexed citations
20.
Ando, Mizuo, Masao Asai, Masafumi Yoshida, et al.. (2010). An attempt to control recurrent lesions in the para-hyoid area in oral tongue cancer. Toukeibu Gan. 36(3). 303–308. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026